Recs

13

This Just In: Upgrades and Downgrades

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

At The Motley Fool, we poke plenty of fun at Wall Street analysts and their endless cycle of upgrades, downgrades, and "initiating coverage at neutral." So you might think we'd be the last people to give virtual ink to such "news." And we would be -- if that were all we were doing.

But in "This Just In," we don't simply tell you what the analysts said. We'll also show you whether they know what they're talking about. To help, we've enlisted Motley Fool CAPS, our tool for rating stocks and analysts alike. With CAPS, we'll be tracking the long-term performance of Wall Street's best and brightest -- and its worst and sorriest, too.

And speaking of the best ...
"Best" may not be quite the right word to describe Cowen & Co. But in a world where stock shops like JPMorgan and Citigroup are flailing around near the 20th percentile of ranked CAPS investors, I'll take advice from 70th-percentiler Cowen over the "wisdom" espoused by its name-brand peers any day of the week. And especially the advice that Cowen gave us yesterday, when it upgraded Northrop Grumman (NYSE: NOC  ) to "outperform."

Let's go to the tape
Why? Well consider from whom the advice is coming. Perhaps best known for its prescient pick of First Solar (back before it became famous), and a string of biotech victories ...

Company

Cowen Said:

CAPS Says:

Cowen's Pick Beating S&P by:

First Solar (Nasdaq: FSLR  )

Outperform

**

483 points

Barr Pharmaceuticals (NYSE: BRL  )

Outperform

****

94 points

ViroPharma  (Nasdaq: VPHM  )

Outperform

*****

58 points

... Cowen's overall performance as a stock picker looks rather hit-or-miss -- emphasis on "miss." 58% of the time Cowen tells you a stock will rise, or that it will fall, the cussed thing goes and does the opposite. Were it not for such home run hits as the three named above, the analyst would be doing far worse than its current average 2.5%-per-pick outperformance of the S&P 500 suggests.

But here's the thing
In contrast to its scattershot record overall, Cowen has put together an amazing string of success stories in the defense industry:

Company

Cowen Said:

CAPS Says:

Cowen's Pick Beating S&P by:

Raytheon (NYSE: RTN  )

Outperform

****

37 points

SAIC (NYSE: SAI  )

Outperform

****

26 points

General Dynamics (NYSE: GD  )

Outperform

****

15 points

It seems everything defense-related that Cowen touches, turns to gold. And so when the analyst defied conventional wisdom yesterday, and declared that defense contractor Northrop would outperform the market as well, you know I listened up.

According to Cowen, investors have overestimated the risk that the Obama administration poses to defense contractors generally, and Northrop in particular. Cowen's rationale: U.S. contractors operate in the U.S. (natch), therefore spending government money on weapons programs "helps boost the economy" -- a key Obama objective. And while Cowen admits that a drawdown of troop levels in Iraq poses some risk to overall defense spending, Northrop's exposure to Iraq is "limited" in scope.

Meanwhile, Cowen says Northrop has a "hedged portfolio of ramping tactical aircraft work" to help keep its business booming. My own impression of trends in the defense sector tells me that Cowen is right on target here. In particular, Northrop is fast becoming the dominant player in larger unmanned aerial vehicles, one area of the military that President-elect Obama has stated publicly he intends to support and expand.

In addition to all the above, Northrop offers investors an attractive valuation today, even after the post-upgrade run-up. The stock sells for a P/E of less than 10, despite analyst expectations of long-term growth north of 13%, and as a bonus, Northrop is currently generating free cash flows superior to what it reports as net income under GAAP.

Foolish takeaway
Its spotty record elsewhere notwithstanding, defense is one sector Cowen knows well, and its analysis of Northrop is spot on. When this banker tells you to buy Northrop Grumman, you'd be well advised to listen.

On Jan. 12, 2009, Fool co-founder David Gardner, Jeff Fischer, and their Motley Fool Pro team will accept new subscribers to their real-money portfolio service. Motley Fool Pro is investing $1 million of the Fool's own money in long and short positions in a range of securities, including common stocks, put and call options, and exchange-traded funds (ETFs). They also incorporate proprietary CAPS "community intelligence" data into their research. To learn more about Motley Fool Pro and to receive a private invitation to join, simply enter your email address in the box below.

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Fool contributor Rich Smith does not own shares of any company named above. You can find him on CAPS, publicly pontificating under the handle TMFDitty, where he's currently ranked No. 1,052 out of more than 125,000 members. SAIC is a Motley Fool Inside Value pick. JPMorgan is an Income Investor choice. The Fool has a disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 804659, ~/Articles/ArticleHandler.aspx, 2/14/2012 10:12:07 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,878.28 4.24 0.03%
S&P 500 1,350.50 -1.27 -0.09%
NASD 2,931.83 0.44 0.02%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/14/2012 4:02 PM
NOC $60.21 Down -0.09 -0.15%
Northrop Grumman C… CAPS Rating: ***
RTN $50.36 Up +0.05 +0.10%
Raytheon Company CAPS Rating: ****
SAI $12.61 Down -0.05 -0.39%
SAIC, Inc. CAPS Rating: ***
VPHM $31.50 Up +0.22 +0.70%
ViroPharma, Inc. CAPS Rating: ****
BRL.DL $65.80 Down +0.00 +0.00%
Barr Pharmaceutica… CAPS Rating: ****
FSLR $39.21 Down -2.51 -6.02%
First Solar CAPS Rating: **
GD $70.16 Up +0.04 +0.06%
General Dynamics C… CAPS Rating: ****

Advertisement